Literature DB >> 9877519

Relationship between electrocardiographic voltage and geometric patterns of left ventricular hypertrophy in patients with essential hypertension.

S Tomita1, H Ueno, M Takata, K Yasumoto, F Tomoda, H Inoue.   

Abstract

To assess whether we could predict left ventricular (LV) geometric patterns on echocardiography from voltages in standard electrocardiograms (ECG) in patients with essential hypertension, standard 12-lead ECG and echocardiograms were recorded in 106 consecutive, untreated patients (50+/-11 yr old) with essential hypertension. Subjects were assigned to the following four groups based on relative wall thickness (RWT) and LV mass index (LVMI) as determined by echocardiography: a normal geometry group (n = 44), a concentric remodeling group (increased RWT and normal LVMI, n = 10), an eccentric hypertrophy group (increased LVMI and normal RWT, n = 23), and a concentric hypertrophy group (increased RWT and LVMI, n = 29). The following ECG variables were determined: Sokolow-Lyon voltage (SV1 = RV5: SL), Cornell voltage (RaVL + SV3: CN), sum of 12-lead QRS voltage (12-lead sum), and RV6/RV5 ratio (RV6/V5). LVMI correlated with SL, CN, and 12-lead sum, but not with RV6/V5 in the study group as a whole. The concentric hypertrophy group showed increased voltages for all ECG variables except RV6/V5. The concentric remodeling group showed increased voltages for SL and 12-lead sum, but a decreased RV6/V5 ratio. In contrast, the eccentric hypertrophy group had increased voltage only for the 12-lead sum. The combination of SL, RV6/V5, and CN showed modest sensitivity and specificity in the diagnosis of concentric remodeling, concentric hypertrophy, and normal geometry, but not in the diagnosis of eccentric hypertrophy. Conventional ECG criteria can predict LVMI, but not LV geometry in the patients with essential hypertension. The combination of SL, CN, and RV6/V5 is useful in differentiating the four LV geometric patterns seen in essential hypertension.

Entities:  

Mesh:

Year:  1998        PMID: 9877519     DOI: 10.1291/hypres.21.259

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  6 in total

1.  Left ventricular hypertrophy by electrocardiogram as a predictor of success in home blood pressure control: HOMED-BP study.

Authors:  Ayumi Tanabe; Kei Asayama; Tomohiro Hanazawa; Daisuke Watabe; Kyoko Nomura; Tomonori Okamura; Takayoshi Ohkubo; Yutaka Imai
Journal:  Hypertens Res       Date:  2017-01-12       Impact factor: 3.872

2.  Assessment of a new electrocardiographic criterion for the diagnosis of left ventricle hypertrophy: A prospective validation study.

Authors:  Kudret Keskin; Ozgur Selim Ser; Gunes Melike Dogan; Gokhan Cetinkal; Suleyman Sezai Yildiz; Serhat Sigirci; Kadriye Kilickesmez
Journal:  North Clin Istanb       Date:  2019-07-09

3.  Modified Cornell electrocardiographic criteria in the assessment of left ventricular hypertrophy geometry of patients with essential hypertension.

Authors:  Min Xu; Zhixiang Ge; Jun Huang; Xiaoliang Shao; Jumei Li; Junhua Yang
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-08       Impact factor: 3.738

4.  Deep learning assessment of left ventricular hypertrophy based on electrocardiogram.

Authors:  Xiaoli Zhao; Guifang Huang; Lin Wu; Min Wang; Xuemin He; Jyun-Rong Wang; Bin Zhou; Yong Liu; Yesheng Lin; Dinghui Liu; Xianguan Yu; Suzhen Liang; Borui Tian; Linxiao Liu; Yanming Chen; Shuhong Qiu; Xujing Xie; Lanqing Han; Xiaoxian Qian
Journal:  Front Cardiovasc Med       Date:  2022-08-11

5.  Electrocardiographic Versus Echocardiographic Left Ventricular Hypertrophy in Severe Aortic Stenosis.

Authors:  Aleksandra Budkiewicz; Michał A Surdacki; Aleksandra Gamrat; Katarzyna Trojanowicz; Andrzej Surdacki; Bernadeta Chyrchel
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

6.  Accuracy of the novel Peguero Lo-Presti criterion for electrocardiographic detection of left ventricular hypertrophy in a black African population.

Authors:  Ulrich Flore Nyaga; Jerôme Boombhi; Alain Menanga; Morike Mokube; Carine Sandrine Ndomo Mevoula; Samuel Kingue; Jean Jacques Noubiap
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-03-29       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.